• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.

作者信息

Stratigos Alexander J, Sekulic Aleksandar, Peris Ketty, Bechter Oliver, Prey Sorilla, Lewis Karl D, Basset-Seguin Nicole, Chang Anne Lynn S, Dalle Stéphane, Fernández Orland Almudena, Licitra Lisa, Robert Caroline, Ulrich Claas, Hauschild Axel, Migden Michael R, Dummer Reinhard, Yoo Suk-Young, Okoye Emmanuel, Bassukas Ioannis, Loquai Carmen, De Giorgi Vincenzo, Eroglu Zeynep, Gutzmer Ralf, Ulrich Jens, Puig Susana, Inocencio Timothy J, Chen Chieh-I, LaFontaine Patrick R, Seebach Frank, Lowy Israel, Fury Matthew G

机构信息

Department of Dermatology-Venereology, Andreas Sygros Hospital-National and Kapodistrian University of Athens, Athens, Greece.

Department of Dermatology, Arizona Mayo Clinic, Scottsdale, Arizona.

出版信息

J Am Acad Dermatol. 2024 Feb;90(2):414-418. doi: 10.1016/j.jaad.2023.08.111. Epub 2023 Oct 14.

DOI:10.1016/j.jaad.2023.08.111
PMID:37839734
Abstract
摘要

相似文献

1
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.西米普利单抗用于刺猬抑制剂治疗后局部晚期基底细胞癌患者的2期开放标签、多中心、单臂研究：延长随访
J Am Acad Dermatol. 2024 Feb;90(2):414-418. doi: 10.1016/j.jaad.2023.08.111. Epub 2023 Oct 14.
2
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.西妥昔单抗治疗后局部晚期基底细胞癌：一项开放标签、多中心、单臂、2 期临床试验。
Lancet Oncol. 2021 Jun;22(6):848-857. doi: 10.1016/S1470-2045(21)00126-1. Epub 2021 May 14.
3
Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial.在一项 II 期临床试验中，接受西普单抗治疗的局部晚期基底细胞癌患者的生活质量。
Future Oncol. 2024;20(30):2249-2258. doi: 10.1080/14796694.2024.2358670. Epub 2024 Jul 29.
4
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors.在使用刺猬通路抑制剂后，西米普利单抗治疗转移性基底细胞癌的II期结果的最终分析。
Ann Oncol. 2024 Feb;35(2):221-228. doi: 10.1016/j.annonc.2023.10.123. Epub 2023 Dec 9.
5
Cemiplimab for locally advanced and metastatic basal cell carcinoma.西米普利单抗用于局部晚期和转移性基底细胞癌。
Expert Rev Anticancer Ther. 2022 Mar;22(3):243-248. doi: 10.1080/14737140.2022.2043748. Epub 2022 Feb 22.
6
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.局部晚期基底细胞癌患者停用西米普利单抗后的持久反应。
Clin Exp Dermatol. 2021 Dec;46(8):1612-1614. doi: 10.1111/ced.14804. Epub 2021 Jul 29.
7
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.CASE（西米普利单抗-rwlc的生存情况与流行病学）：一项针对晚期基底细胞癌的研究。
Future Oncol. 2025 Feb;21(4):431-436. doi: 10.1080/14796694.2024.2448416. Epub 2025 Jan 11.
8
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.西妥昔单抗治疗局部晚期皮肤鳞状细胞癌：一项开放标签、2 期、单臂试验的结果。
Lancet Oncol. 2020 Feb;21(2):294-305. doi: 10.1016/S1470-2045(19)30728-4. Epub 2020 Jan 14.
9
Libtayo (Cemiplimab-rwlc) Injection for Intravenous Use.注射用利特昔单抗（西姆利单抗）。
Skinmed. 2024 Aug 2;22(2):138-143. eCollection 2024.
10
Health-related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial.转移性基底细胞癌患者接受西普单抗治疗的健康相关生活质量：一项 2 期试验分析。
Cancer Med. 2024 Jul;13(14):e7360. doi: 10.1002/cam4.7360.

引用本文的文献

1
Advanced Basal Cell Carcinoma: A Narrative Review on Current Systemic Treatments and the Neoadjuvant Approach.晚期基底细胞癌：关于当前全身治疗及新辅助治疗方法的叙述性综述
J Pers Med. 2025 Jun 1;15(6):226. doi: 10.3390/jpm15060226.
2
Managing Advanced Basal Cell Carcinoma: A Guide for the Dermatology Clinician.晚期基底细胞癌的管理：皮肤科临床医生指南
J Clin Aesthet Dermatol. 2025 Mar;18(3):21-27.
3
Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma.在局部晚期基底细胞癌中，对索尼德吉产生继发性耐药的情况较为罕见。
J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e788-e790. doi: 10.1111/jdv.20629. Epub 2025 Mar 8.
4
Therapeutic Approaches for Advanced Basal Cell Carcinoma: A Comprehensive Review.晚期基底细胞癌的治疗方法：综述
Cancers (Basel). 2024 Dec 29;17(1):68. doi: 10.3390/cancers17010068.
5
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances.非黑色素瘤皮肤癌的系统治疗：最新进展。
Curr Oncol Rep. 2024 Sep;26(9):1120-1133. doi: 10.1007/s11912-024-01570-1. Epub 2024 Jul 2.